Capital World Investors Astrazeneca PLC Transaction History
Capital World Investors
- $586 Billion
- Q1 2024
A detailed history of Capital World Investors transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital World Investors holds 9,365,676 shares of AZN stock, worth $731 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
9,365,676
Previous 9,336,179
0.32%
Holding current value
$731 Million
Previous $629 Million
0.91%
% of portfolio
0.11%
Previous 0.11%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,244Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...